高密度脂蛋白与心血管疾病：益处、弊端与未来II
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II.
作者信息
Julve Josep, Escolà-Gil Joan Carles
机构信息
Institut d'Investigacions Biomèdiques IIB Sant Pau, 08041 Barcelona, Spain.
CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), 28029 Madrid, Spain.
出版信息
Biomedicines. 2022 Mar 7;10(3):620. doi: 10.3390/biomedicines10030620.
Abstract
The notion that high-density lipoproteins (HDL) are atheroprotective is supported by different lines of evidence [...].
摘要
高密度脂蛋白（HDL）具有抗动脉粥样硬化作用这一观点得到了不同证据的支持[...]。
相似文献
1
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future II.高密度脂蛋白与心血管疾病：益处、弊端与未来II
Biomedicines. 2022 Mar 7;10(3):620. doi: 10.3390/biomedicines10030620.
2
Current Therapies Focused on High-Density Lipoproteins Associated with Cardiovascular Disease.目前针对与心血管疾病相关的高密度脂蛋白的治疗方法。
Molecules. 2018 Oct 23;23(11):2730. doi: 10.3390/molecules23112730.
3
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad, and the Future.高密度脂蛋白与心血管疾病：好、坏与未来。
Int J Mol Sci. 2021 Jul 13;22(14):7488. doi: 10.3390/ijms22147488.
4
High-Density Lipoproteins and Cardiovascular Disease: The Good, the Bad and the Future.高密度脂蛋白与心血管疾病：益处、弊端与未来
Biomedicines. 2021 Jul 22;9(8):857. doi: 10.3390/biomedicines9080857.
5
[The biological activity of high-density lipoprotein fractions and their role in the development of cardiovascular diseases].[高密度脂蛋白组分的生物活性及其在心血管疾病发生发展中的作用]
Ter Arkh. 2016;88(9):111-118. doi: 10.17116/terarkh2016889111-118.
6
Native high density lipoproteins (HDL) interfere with platelet activation induced by oxidized low density lipoproteins (OxLDL).天然高密度脂蛋白（HDL）可干扰氧化型低密度脂蛋白（OxLDL）诱导的血小板活化。
Int J Mol Sci. 2013 May 10;14(5):10107-21. doi: 10.3390/ijms140510107.
7
Beginning to understand high-density lipoproteins.开始了解高密度脂蛋白。
Endocrinol Metab Clin North Am. 2014 Dec;43(4):913-47. doi: 10.1016/j.ecl.2014.08.001.
8
Antiatherogenic functionality of high density lipoprotein: how much versus how good.高密度脂蛋白的抗动脉粥样硬化功能：量与质的比较
J Atheroscler Thromb. 2008 Apr;15(2):52-62. doi: 10.5551/jat.e571. Epub 2008 Apr 3.
9
Subfractions and subpopulations of HDL: an update.高密度脂蛋白的亚组分和亚群：最新进展
Curr Med Chem. 2014;21(25):2881-91. doi: 10.2174/0929867321666140414103455.
10
Targeting high-density lipoproteins: update on a promising therapy.靶向高密度脂蛋白：有前途的治疗方法的最新进展。
Arch Cardiovasc Dis. 2013 Nov;106(11):601-11. doi: 10.1016/j.acvd.2013.06.052. Epub 2013 Sep 25.
引用本文的文献
1
Excessive Consumption of Alcoholic Beverages and Extremely High Levels of High-Density Lipoprotein Cholesterol (HALP) in the ELSA-Brasil Cohort Baseline.巴西 ELSA 队列基线中酒精饮料过度消耗和极高水平高密度脂蛋白胆固醇（HALP）。
Nutrients. 2023 Feb 28;15(5):1221. doi: 10.3390/nu15051221.
本文引用的文献
1
HDL Is Not Dead Yet.高密度脂蛋白尚未“死亡”。
Biomedicines. 2022 Jan 7;10(1):128. doi: 10.3390/biomedicines10010128.
2
The Capacity of APOB-Depleted Plasma in Inducing ATP-Binding Cassette A1/G1-Mediated Macrophage Cholesterol Efflux-But Not Gut Microbial-Derived Metabolites-Is Independently Associated with Mortality in Patients with ST-Segment Elevation Myocardial Infarction.载脂蛋白B缺乏血浆诱导ATP结合盒转运体A1/G1介导的巨噬细胞胆固醇流出的能力——而非肠道微生物衍生代谢产物——与ST段抬高型心肌梗死患者的死亡率独立相关。
Biomedicines. 2021 Sep 27;9(10):1336. doi: 10.3390/biomedicines9101336.
3
Apolipoprotein Signature of HDL and LDL from Atherosclerotic Patients in Relation with Carotid Plaque Typology: A Preliminary Report.动脉粥样硬化患者高密度脂蛋白和低密度脂蛋白的载脂蛋白特征与颈动脉斑块类型的关系：初步报告
Biomedicines. 2021 Sep 3;9(9):1156. doi: 10.3390/biomedicines9091156.
4
High-Density Lipoprotein Subfractions: Much Ado about Nothing or Clinically Important?高密度脂蛋白亚组分：无事生非还是具有临床重要性？
Biomedicines. 2021 Jul 18;9(7):836. doi: 10.3390/biomedicines9070836.
5
Familial Hypercholesterolemia: Do HDL Play a Role?家族性高胆固醇血症：高密度脂蛋白发挥作用吗？
Biomedicines. 2021 Jul 13;9(7):810. doi: 10.3390/biomedicines9070810.
6
HDL Dysfunctionality: Clinical Relevance of Quality Rather Than Quantity.高密度脂蛋白功能障碍：质量而非数量的临床相关性。
Biomedicines. 2021 Jun 25;9(7):729. doi: 10.3390/biomedicines9070729.
7
Structure and Dynamics of Oxidized Lipoproteins In Vivo: Roles of High-Density Lipoprotein.体内氧化脂蛋白的结构与动力学：高密度脂蛋白的作用
Biomedicines. 2021 Jun 8;9(6):655. doi: 10.3390/biomedicines9060655.
8
HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.21 世纪的高密度脂蛋白：未来高密度脂蛋白研究的多功能路线图。
Circulation. 2021 Jun 8;143(23):2293-2309. doi: 10.1161/CIRCULATIONAHA.120.044221. Epub 2021 Jun 7.
9
Subpopulations of High-Density Lipoprotein: Friends or Foes in Cardiovascular Disease Risk in Chronic Kidney Disease?高密度脂蛋白亚群：慢性肾脏病心血管疾病风险中的友或敌？
Biomedicines. 2021 May 16;9(5):554. doi: 10.3390/biomedicines9050554.
10
Fetal High-Density Lipoproteins: Current Knowledge on Particle Metabolism, Composition and Function in Health and Disease.胎儿高密度脂蛋白：关于健康与疾病中颗粒代谢、组成及功能的当前认知
Biomedicines. 2021 Mar 30;9(4):349. doi: 10.3390/biomedicines9040349.
Zotero 插件